SYF Insider Filing: Dividend Equivalent Units and Deferred-Comp Phantom Units Reported
Rhea-AI Filing Summary
Alberto Casellas, an officer of Synchrony Financial (SYF) reported transactions dated 08/15/2025. The Form 4 discloses 56,917 dividend equivalent units accrued on restricted stock units, described as economic equivalents of one share each and vesting and settling on the same terms as the underlying restricted stock units. The filing also reports acquisition of phantom stock units under the Synchrony Financial Deferred Compensation Plan, which will be settled in cash six months after the reporting person separates from service; each phantom unit is the economic equivalent of one share. The form was signed by an attorney-in-fact on 08/19/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine executive compensation entries showing dividend equivalents and deferred-compensation phantom units; no sale or outside transactions reported.
This Form 4 records non-sales compensation-related entries rather than open-market trades. The 56,917 dividend equivalent units reflect accrued dividends on restricted stock units that vest and settle on the same terms as the underlying awards, which is typical for aligning executive pay with shareholder outcomes. The phantom stock units were acquired under a deferred compensation plan and are payable in cash six months after separation, indicating a deferred cash payout vehicle rather than immediate equity dilution. No dispositions or open-market purchases by the reporting person are shown.
TL;DR: Compensation mechanics disclosed; dividend-equivalent accruals and deferred-compensation phantom units are standard plan-driven events.
The disclosure describes plan-driven accruals: dividend equivalent units tied to restricted stock units and phantom stock units acquired via a dividend reinvestment feature in the Deferred Compensation Plan. The phantom units carry a cash settlement timing provision (six months post-separation), which affects executive liquidity and tax timing but does not immediately change share count. Documentation includes the reporting persons title as EVP, CEO--Health & Wellness, confirming officer status for Section 16 reporting.